Slumping AI stocks could be really good news for your nontech holdings, says market strategist
Katie Stockton, of Fairlead Strategies, said she is seeing strong buying momentum in the healthcare, industrial, biotech, insurance and utility sectors…
Major drugmaker loses $27 billion in market value after failed trial
Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial. Source：MarketWatch
Trump floats idea of Australia’s retirement system again. But what about Social Security?
The president said his administration was working on a plan based on the Austrialian system, days after the launch of “Trump accounts” for children.…
There’s a 67% chance stocks will suffer a bear market when this rare signal flashes — like it’s doing now
The Dow Industrials are trouncing the Nasdaq composite. That’s an alarming sign for your portfolio. Source：MarketWatch
FTX exec’s wife scheduled for November trial on campaign finance charges
A Manhattan judge ordered that Michelle Bond’s criminal trial start in November after he denied a motion to dismiss the indictment based on claims that…
FTX's Sam Bankman-Fried loses appeal of criminal conviction on fraud, conspiracy charges
The onetime FTX CEO did not persuade a panel of judges that his trial was unfair, the appeals court panel ruled Friday. Source：CoinDesk